siRNA-Mediated Timp1 Silencing Inhibited the Inflammatory Phenotype during Acute Lung Injury

Int J Mol Sci. 2023 Jan 13;24(2):1641. doi: 10.3390/ijms24021641.

Abstract

Acute lung injury is a complex cascade process that develops in response to various damaging factors, which can lead to acute respiratory distress syndrome. Within this study, based on bioinformatics reanalysis of available full-transcriptome data of acute lung injury induced in mice and humans by various factors, we selected a set of genes that could serve as good targets for suppressing inflammation in the lung tissue, evaluated their expression in the cells of different origins during LPS-induced inflammation, and chose the tissue inhibitor of metalloproteinase Timp1 as a promising target for suppressing inflammation. We designed an effective chemically modified anti-TIMP1 siRNA and showed that Timp1 silencing correlates with a decrease in the pro-inflammatory cytokine IL6 secretion in cultured macrophage cells and reduces the severity of LPS-induced acute lung injury in a mouse model.

Keywords: IL6; LPS; TIMP1; acute lung injury; bioinformatics analysis; chemically modified siRNA; inflammation.

MeSH terms

  • Acute Lung Injury* / genetics
  • Acute Lung Injury* / metabolism
  • Animals
  • Humans
  • Inflammation / genetics
  • Inflammation / metabolism
  • Lipopolysaccharides / pharmacology
  • Lung / drug effects
  • Lung / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Phenotype
  • RNA, Small Interfering* / genetics
  • RNA, Small Interfering* / pharmacology
  • Tissue Inhibitor of Metalloproteinase-1 / genetics
  • Tissue Inhibitor of Metalloproteinase-1 / metabolism

Substances

  • Lipopolysaccharides
  • RNA, Small Interfering
  • TIMP1 protein, human
  • Timp1 protein, mouse
  • Tissue Inhibitor of Metalloproteinase-1